Detalhe da pesquisa
1.
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
J Hematol Oncol
; 11(1): 124, 2018 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30305115